Antisense Oligonucleotide Therapies: The Promise and the Challenges from a Toxicologic Pathologist’s Perspective
Year: 2014
Type: review
Source: Toxicologic Pathology
Author: Kendall S. Frazier
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2114775015
